Many people tolerate them well, but the IV route carries higher risks, including infection and severe allergic reactions
The rise of Lillys and Novo Nordisks GLP-1 drugs has given new life to the market for obesity drugs overall
Ortega-FerrusolaCGonzlez-FernndezLMurielAMacas-GarcaBRodrguez-MartnezHTapiaJAet al
In this work we assume that the ensemble of multi-task convolutional neural networks makes reliable predictions up to three mutation steps from the closest training-set analogue sequence
Swiss Webster female mice were purchased from Charles River Laboratories (Wilmington, MA, USA)
Jensterle M, Kravos NA, Pfeifer M, Kocjan T, Janez A (2015) A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome